Articles, guides, and regulatory updates from our community.
A major 2025 BMJ network meta-analysis of 262 trials compares 19 obesity drugs on weight loss, safety, and cardiovascular outcomes. Here's what patients should know.
By Peptide Association Research Team
A 2026 NIDDK workshop study examines how real-world evidence can fill critical gaps in GLP-1 receptor agonist safety, effectiveness, and coverage decisions.
By Peptide Association Research Team
New 2026 research reveals wide geographic disparities in access to peptide-based sexual medicine therapies driven by state telehealth, NP, and compounding laws.
By Peptide Association Research Team
New research suggests a biomimetic hematoma scaffold may enable ultra-low-dose BMP-2 to outperform standard collagen sponge delivery in large bone defect repair.
By Peptide Association Research Team
A 2026 clinical study suggests HMB supplementation may support immune response and intracellular amino acid synthesis in critically ill ICU patients.
By Peptide Association Research Team
New research explores how IL-15 and Thymosin α1 may reduce immune aging in hepatocellular carcinoma. Learn what the findings mean for future cancer therapy.
By Peptide Association Research Team
New research suggests elamipretide (SS-31) may support recovery after spinal cord injury by preserving mitochondrial function and reducing cell death in animal models.
By Peptide Association Research Team
A 2026 critical review examines peptide use in competitive and recreational sport, highlighting limited clinical evidence and emerging health risks. Read the findings.
By Peptide Association Research Team
New research explores how copper peptide GHK-Cu combined with glucose oxidase may support diabetic wound healing through cascade catalysis. Learn what the study found.
By Peptide Association Research Team
New research explores how IL-15 and Thymosin α1 may reduce immune cell aging in hepatocellular carcinoma. Learn what the findings mean for patients.
By Peptide Association Research Team
New research explores how IL-15 and Thymosin α1 may reduce immune cell aging in liver cancer. Learn what this study found and what it means for patients.
By Peptide Association Research Team
A 2026 critical review reveals growing peptide use in sport and bodybuilding, with limited clinical evidence and poorly defined long-term safety risks.
By Peptide Association Research Team
New research explores GHK-Cu peptide microspheres for bone repair, suggesting dual osteogenic and angiogenic activity in laboratory models. Learn what this means.
By Peptide Association Research Team
New research suggests thymosin alpha-1 may restore cancer-fighting immunity suppressed by chemotherapy. Learn what this 2026 study found and why it matters.
By Peptide Association Research Team
New research explores how L-aspartic acid-derived materials may enable smarter, programmable drug delivery systems. Learn what the science says.
By Peptide Association Research Team
New research reveals how diabetes silently damages heart blood vessels and nerve signaling—raising alarms about undetected cardiac risk in diabetic patients.
By Peptide Association Research Team
New research explores GHK-Cu peptide microspheres for bone repair. Learn what the study found about osteogenic and angiogenic activity in this evidence-based review.
By Peptide Association Research Team
New research suggests thymosin alpha-1 may help restore anti-tumor immunity after chemotherapy by activating dendritic cells. Learn what the study found.
By Peptide Association Research Team
A 2026 study found BPC-157 and hybrid analogs may inhibit acetylcholinesterase, a key enzyme in Alzheimer's disease. Learn what the research means.
By Peptide Association Research Team
New research links mitochondrial dysfunction and oxidative stress to gestational diabetes, placental problems, and offspring metabolic risk. Learn what the science shows.
By Peptide Association Research Team
New research on GHK-Cu peptide suggests delivery route significantly affects cognitive outcomes in aged mice. Learn what the science says and what it means for you.
By Peptide Association Research Team
New research explores oleogel systems that may improve resveratrol bioavailability. Learn what the 2026 Food Chemistry study found and what it means for supplementation.
By Peptide Association Research Team
New research identifies cathepsin B as a key driver of gut barrier breakdown in alcohol-associated liver disease. Learn what the study found and why it matters.
By Peptide Association Research Team
New research explores how GLP-1 receptor agonists affect skin biology, inflammation, wound healing, and aesthetic aging. Learn what the evidence shows.
By Peptide Association Research Team